Conformational alterations of bovine hemoglobin (Hb) upon sequential addition of glyoxal over a range of 0–90% v/v were investigated. At 20% v/v glyoxal, molten globule (MG) state of Hb was observed by altered tryptophan fluorescence, high ANS binding, existence of intact heme, native-like secondary structure as depicted by far-UV circular dichroism (CD) and ATR-FTIR spectra as well as loss in tertiary structure as confirmed by near-UV CD spectra. In addition, size exclusion chromatography analysis depicted that MG state at 20% v/v glyoxal corresponded to expanded pre-dissociated dimers. Aggregates of Hb were detected at 70% v/v glyoxal. These aggregates of Hb had altered tryptophan environment, low ANS binding, exposed heme, increased β-sheet secondary structure, loss in tertiary structure, enhanced thioflavin T (ThT) fluorescence and red shifted Congo Red (CR) absorbance. On incubating Hb with 30% v/v glyoxal for 0–20 days, advanced glycation end products (AGEs) were detected on day 20. These AGEs were characterised by enhanced tryptophan fluorescence at 450 nm, exposure of heme, increase in intermolecular β-sheets, enhanced ThT fluorescence and red shift in CR absorbance. Comet assay revealed aggregates and AGEs to be genotoxic in nature. Scanning electron microscopy confirmed the amorphous structure of aggregates and branched fibrils of AGEs. The transformation of α-helix to β-sheet usually alters the normal protein to amyloidogenic resulting in a variety of protein conformational disorders such as diabetes, prion and Huntington's.

No abstract

No abstract

No abstract

Protein folding is a very complex process, and recognition of the molecular mechanisms responsible for protein folding is one of the demanding queries in biochemistry. Protein molecules have a fixed propensity either to misfold or unable to sustain their precisely folded states, under assured conditions. Taking into account that the protein misfolding and aggregation are central in the pathogenesis of protein conformational disorders, a therapy focussed to the root of the disease should target to restrain and/or undo the conformational alterations that lead to the development of the pathological protein conformer. In future, an understanding of the causes of protein aggregation and genetic and environmental vulnerability features of an exact individual may offer an enhanced prospect for a successful therapeutic intrusion. Dealing with these and related problems not only provides great prospects for involvement with numerous, presently fatal diseases but will also ultimately disclose the basically essential association between proteostasis and prolonged existence.